Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
47.60
+0.19 (+0.40%)
Streaming Delayed Price
Updated: 12:35 PM EDT, Jun 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,328,176
Open
47.81
Bid (Size)
47.59 (1,900)
Ask (Size)
47.60 (1,500)
Prev. Close
47.41
Today's Range
47.39 - 48.24
52wk Range
35.12 - 71.80
Shares Outstanding
N/A
Dividend Yield
5.36%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?
↗
Today 11:38 EDT
Novo Nordisk is no longer the front-runner, but it's not out of the running, either.
Via
The Motley Fool
The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch
↗
Today 2:20 EDT
These companies' innovative qualities could help them get ahead of their peers in capitalizing on AI.
Via
The Motley Fool
Topics
Artificial Intelligence
Performance
YTD
-9.1%
-9.1%
1 Month
+7.7%
+7.7%
3 Month
+31.0%
+31.0%
6 Month
-9.4%
-9.4%
1 Year
-32.7%
-32.7%
More News
Read More
2 Underrated Weight Loss Stocks to Buy and Hold
↗
June 23, 2026
Via
The Motley Fool
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
↗
June 22, 2026
Via
The Motley Fool
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?
↗
June 20, 2026
Via
The Motley Fool
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
↗
June 20, 2026
Via
MarketBeat
Topics
ETFs
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
↗
June 16, 2026
Via
The Motley Fool
3 Under-the-Radar Stocks to Buy and Hold for a Decade
↗
June 16, 2026
Via
The Motley Fool
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
↗
June 14, 2026
Via
The Motley Fool
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About
↗
June 12, 2026
Via
The Motley Fool
Is Viking Therapeutics Stock Going to $100?
↗
June 12, 2026
Via
The Motley Fool
Why Pfizer Stock Popped Today
↗
June 11, 2026
Via
The Motley Fool
80% of Wegovy Pill Users Never Took a Weight Loss Drug Before. Does This Number Change the Entire Novo Nordisk Bear Case?
↗
June 07, 2026
Via
The Motley Fool
Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?
↗
June 06, 2026
Via
The Motley Fool
Topics
Intellectual Property
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors
↗
June 05, 2026
Via
The Motley Fool
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
↗
June 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better
↗
June 03, 2026
Via
The Motley Fool
Here's What I Think Is Really Going on With Novo Nordisk Stock
↗
June 03, 2026
Via
The Motley Fool
Bull vs. Bear: The Quick Take on Viking Therapeutics Stock
↗
June 03, 2026
Via
The Motley Fool
Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage
↗
June 02, 2026
Via
MarketBeat
Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down
↗
June 02, 2026
Via
The Motley Fool
Lexicon (LXRX) Q1 2026 Earnings Transcript
↗
June 01, 2026
Via
The Motley Fool
Is Eli Lilly Starting an Nvidia-Style Run?
↗
June 01, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
5 Best Growth Stocks for the Next 10 Years
↗
May 31, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors
↗
May 30, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 47.60
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 06/25/26 12:35 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
